Residue Cys-67 of HLA-B27 contributes to antigen presentation and T cell recognition of HLA-B27 restricted T cell epitopes.

Residue Cys-67 of HLA-B27 contributes to antigen presentation and T cell recognition of HLA-B27 restricted T cell epitopes.

Detalhes bibliográficos
Principais autores:	Appel, H, Kuhne, M, Kuon, W, Kuhlmann, S, Kollnberger, S, Weiss, E, Bowness, P, Sieper, J
Formato:	Conference item
Publicado em:	2004

Registros relacionados

The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
por: Appel, H, et al.
Publicado em: (2004)

Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
por: Appel, H, et al.
Publicado em: (2004)

Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
por: Appel, H, et al.
Publicado em: (2004)

Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
por: Kuon, W, et al.
Publicado em: (2001)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
por: Wong-Baeza, I, et al.
Publicado em: (2011)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
por: Rysnik, O, et al.
Publicado em: (2012)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
por: Bowness, P, et al.
Publicado em: (2003)

HLA B27 can form heavy chain homodimers in vivo and in vivo, possible role of cys 67.
por: Bowness, P, et al.
Publicado em: (1998)

HLA-B27
por: Bowness, P
Publicado em: (2015)

Factors determining the cell surface expression of a novel HLA-B27 epitope
por: McHugh, K, et al.
Publicado em: (2010)

Identification and characterisation of cell surface HLA-B27 homodimers
por: Bird, L, et al.
Publicado em: (2002)

HLA-B-27 heavy chain homodimer formation and natural killer cell family interaction - comparison of two HLA-B-27 subtypes in vitro
por: Giles, J, et al.
Publicado em: (2008)

Functional characterisation of HLA-B27 in autoimmunity
por: Kollnberger, S, et al.
Publicado em: (2001)

Direct visualisation of HLA-B27 forms in cell lines and Spondyloarthropathy tissues
por: Rysnik, O, et al.
Publicado em: (2013)

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.
por: Osiris Marroquin Belaunzaran, et al.
Publicado em: (2015-01-01)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
por: Bowness, P, et al.
Publicado em: (1995)

Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
por: Kollnberger, S, et al.
Publicado em: (2002)

The role of HLA-B27 in spondyloarthritis.
por: Allen, R, et al.
Publicado em: (1999)

The pathogenesis of spondyloarthritides - HLA-B-27 homodimer expression on human monocyte/macrophage cell lines
por: McHugh, K, et al.
Publicado em: (2008)

HLA-B27 HEAVY CHAIN DIMER EXPRESSION IN SPONDYLOARTHRITIS
por: Rysnik, O, et al.
Publicado em: (2012)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
por: McHugh, K, et al.
Publicado em: (2014)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
por: Kollnberger, S, et al.
Publicado em: (2004)

Jekyll and Hyde: the transformation of HLA-B27.
por: Edwards, J, et al.
Publicado em: (2000)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
por: Bowness, P, et al.
Publicado em: (1995)

Dimers are forever. Expression and recognition of abnormal HLA-B27 in spondylo arthritis
por: Bowness, P, et al.
Publicado em: (2005)

Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.
por: Bird, L, et al.
Publicado em: (2003)

THE ARTHRITIS-ASSOCIATED HLA-B(star)27:05 FORMS MORE CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN HLA(star)B27:09
por: Shaw, J, et al.
Publicado em: (2013)

The role of HLA-B27 interactions with natural killer receptors in the pathogenesis of spondyloarthritis
por: Kollnberger, S, et al.
Publicado em: (2007)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
por: Hatano, H, et al.
Publicado em: (2013)

The biochemistry and immunology of non-canonical forms of HLA-B27
por: Shaw, J, et al.
Publicado em: (2014)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
por: Kollnberger, S, et al.
Publicado em: (2007)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
por: Giles, J, et al.
Publicado em: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
por: Bowness, P, et al.
Publicado em: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
por: Bowness, P, et al.
Publicado em: (2010)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
por: Huet, S, et al.
Publicado em: (1990)

Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.
por: Payeli, S, et al.
Publicado em: (2012)

CELL SURFACE EXPRESSION OF HLA B27 HEAVY CHAINS AND SPECIFIC RECOGNITION BY IMMUNE RECEPTORS, POSSIBLE ROLE IN SPONDYLOARTHROPATHY
por: Kollnberger, S, et al.
Publicado em: (2002)

DIRECT VISUALIZATION OF HLA-B27 FORMS IN CELL LINES AND SPONDYLOARTHROPATHY TISSUES
por: Rysnik, O, et al.
Publicado em: (2013)

Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
por: Joachim Sieper, et al.
Publicado em: (2023-08-01)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
por: McMichael, A, et al.
Publicado em: (2002)